A dual GIP and GLP-1 receptor agonist peptide engineered to alter metabolic function and gastric emptying.
Forces extreme appetite suppression and re-sensitizes insulin receptors, leading to rapid fat loss.
Administered via weekly subcutaneous injections, titrated upward slowly over months.